Abstract Background and Purpose Currently there are no widely accepted guidelines for
chimerism analysis testing in hematopoietic cell transplantation (HCT) patients. The …

This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

Chimerism analysis is a well-established method for monitoring the state of hematopoietic
stem cell transplantation (HSCT) over time by analyzing peripheral blood or bone marrow …

The aim of this study was to evaluate the performance of a novel NGS-based assay to
monitor mixed chimerism (MC) and compare its technical capacity to established techniques …

Recipient–donor chimerism is routinely analyzed after allogeneic hematopoietic stem cell
transplantation (HSCT) to monitor engraftment and graft rejection. For malignancies …

Hematopoietic stem cell transplantation (HSCT) is a curative treatment for most hematologic
diseases. To evaluate the level of donor engraftment, chimerism must be carefully monitored …

HLA loss in hematologic malignancies is rare at diagnosis but may occur in leukemic cells at
disease relapse. Although HLA mismatched hematopoietic cell transplant (HCT) is useful in …

After hematopoietic stem cell transplantation, chimerism assay is a useful approach to
monitor the success of the transplant and to select the appropriate treatment strategy, such …

Chimerism analysis is widely used to aid in the clinical management of patients after
allogeneic hematopoietic stem cell transplantation. Many laboratories currently use assays …

Haematopoietic stem cell transplants (HSCTs) are carried out across the world to treat
haematological and immunological diseases which would otherwise prove fatal. Certain …